PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
4.25%
Growth of 4.25% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
3.67%
Cost growth of 3.67% versus flat Healthcare costs. Walter Schloss would verify cost control.
6.66%
Growth of 6.66% versus flat Healthcare gross profit. Walter Schloss would verify quality.
2.31%
Margin change of 2.31% versus flat Healthcare margins. Walter Schloss would verify quality.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-2.04%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-1.60%
Operating expenses reduction while Healthcare median is 0.54%. Seth Klarman would investigate advantages.
2.77%
Total costs growth exceeding 1.5x Healthcare median of 1.14%. Jim Chanos would check for waste.
No Data
No Data available this quarter, please select a different quarter.
-1.86%
D&A reduction while Healthcare median is 0.97%. Seth Klarman would investigate efficiency.
29.91%
EBITDA change of 29.91% versus flat Healthcare. Walter Schloss would verify quality.
24.61%
Margin change of 24.61% versus flat Healthcare. Walter Schloss would verify quality.
51.13%
Income change of 51.13% versus flat Healthcare. Walter Schloss would verify quality.
44.97%
Margin change of 44.97% versus flat Healthcare. Walter Schloss would verify quality.
1.22%
Other expenses change of 1.22% versus flat Healthcare. Walter Schloss would verify control.
45.93%
Pre-tax income growth exceeding 1.5x Healthcare median of 0.60%. Joel Greenblatt would investigate advantages.
39.98%
Margin change of 39.98% versus flat Healthcare. Walter Schloss would verify quality.
43.90%
Tax expense change of 43.90% versus flat Healthcare. Walter Schloss would verify strategy.
46.91%
Net income growth exceeding 1.5x Healthcare median of 0.21%. Joel Greenblatt would investigate advantages.
40.92%
Margin change of 40.92% versus flat Healthcare. Walter Schloss would verify quality.
46.89%
EPS growth exceeding 1.5x Healthcare median of 5.08%. Joel Greenblatt would investigate advantages.
46.89%
Diluted EPS growth exceeding 1.5x Healthcare median of 5.00%. Joel Greenblatt would investigate advantages.
-0.00%
Share count reduction while Healthcare median is 0.20%. Seth Klarman would investigate strategy.
No Data
No Data available this quarter, please select a different quarter.